Literature DB >> 12758196

Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis.

P J Brennan1.   

Abstract

Much of the early structural definition of the cell wall of Mycobacterium spp. was initiated in the 1960s and 1970s. There was a long period of inactivity, but more recent developments in NMR and mass spectral analysis and definition of the M. tuberculosis genome have resulted in a thorough understanding, not only of the structure of the mycobacterial cell wall and its lipids but also the basic genetics and biosynthesis. Our understanding nowadays of cell-wall architecture amounts to a massive "core" comprised of peptidoglycan covalently attached via a linker unit (L-Rha-D-GlcNAc-P) to a linear galactofuran, in turn attached to several strands of a highly branched arabinofuran, in turn attached to mycolic acids. The mycolic acids are oriented perpendicular to the plane of the membrane and provide a truly special lipid barrier responsible for many of the physiological and disease-inducing aspects of M. tuberculosis. Intercalated within this lipid environment are the lipids that have intrigued researchers for over five decades: the phthiocerol dimycocerosate, cord factor/dimycolyltrehalose, the sulfolipids, the phosphatidylinositol mannosides, etc. Knowledge of their roles in "signaling" events, in pathogenesis, and in the immune response is now emerging, sometimes piecemeal and sometimes in an organized fashion. Some of the more intriguing observations are those demonstrating that mycolic acids are recognized by CD1-restricted T-cells, that antigen 85, one of the most powerful protective antigens of M. tuberculosis, is a mycolyltransferase, and that lipoarabinomannan (LAM), when "capped" with short mannose oligosaccharides, is involved in phagocytosis of M. tuberculosis. Definition of the genome of M. tuberculosis has greatly aided efforts to define the biosynthetic pathways for all of these exotic molecules: the mycolic acids, the mycocerosates, phthiocerol, LAM, and the polyprenyl phosphates. For example, we know that synthesis of the entire core is initiated on a decaprenyl-P with synthesis of the linker unit, and then there is concomitant extension of the galactan and arabinan chains while this intermediate is transported through the cytoplasmic membrane. The final steps in these events, the attachment of mycolic acids and ligation to peptidoglycan, await definition and will prove to be excellent targets for a new generation of anti-tuberculosis drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12758196     DOI: 10.1016/s1472-9792(02)00089-6

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  226 in total

1.  Identification of amino acids involved in catalytic process of M. tuberculosis GlmU acetyltransferase.

Authors:  Yan Zhou; Wendan Yu; Qi Zheng; Yi Xin; Yufang Ma
Journal:  Glycoconj J       Date:  2012-06-06       Impact factor: 2.916

Review 2.  Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis.

Authors:  Jonathan Paul Smith
Journal:  Yale J Biol Med       Date:  2011-12

Review 3.  Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis.

Authors:  L L Flores; K R Steingart; N Dendukuri; I Schiller; J Minion; M Pai; A Ramsay; M Henry; S Laal
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

4.  Development of an extraction method for mycobacterial metabolome analysis.

Authors:  B U Jaki; S G Franzblau; S H Cho; G F Pauli
Journal:  J Pharm Biomed Anal       Date:  2005-11-28       Impact factor: 3.935

Review 5.  Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?

Authors:  Mark L Lang; Aharona Glatman-Freedman
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Crystallization and preliminary X-ray crystallographic studies of the N-terminal domain of FadD28, a fatty-acyl AMP ligase from Mycobacterium tuberculosis.

Authors:  Aneesh Goyal; Malikmohamed Yousuf; Eerappa Rajakumara; Pooja Arora; Rajesh S Gokhale; Rajan Sankaranarayanan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-03-10

7.  Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.

Authors:  Supriya Shukla; Edward T Richardson; Michael G Drage; W Henry Boom; Clifford V Harding
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

8.  Photoactivatable Glycolipid Probes for Identifying Mycolate-Protein Interactions in Live Mycobacteria.

Authors:  Herbert W Kavunja; Kyle J Biegas; Nicholas Banahene; Jessica A Stewart; Brent F Piligian; Jessica M Groenevelt; Caralyn E Sein; Yasu S Morita; Michael Niederweis; M Sloan Siegrist; Benjamin M Swarts
Journal:  J Am Chem Soc       Date:  2020-04-20       Impact factor: 15.419

9.  Transcriptional control of the mycobacterial embCAB operon by PknH through a regulatory protein, EmbR, in vivo.

Authors:  Kirti Sharma; Meetu Gupta; Monika Pathak; Nidhi Gupta; Anil Koul; Smilona Sarangi; Renu Baweja; Yogendra Singh
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

10.  Urinary LAM grade, culture positivity, and mortality among HIV-infected South African out-patients.

Authors:  R W Kubiak; J T Herbeck; S M Coleman; D Ross; K Freedberg; I V Bassett; P K Drain
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.